Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2019 Jan 31;9:1557. doi: 10.3389/fphar.2018.01557

Corrigendum: Seabuckthorn Pulp Oil Protects against Myocardial Ischemia–Reperfusion Injury in Rats through Activation of Akt/eNOS

Kapil Suchal 1,, Jagriti Bhatia 1,, Salma Malik 1, Rajiv Kumar Malhotra 1, Nanda Gamad 1, Sameer Goyal 2, Tapas C Nag 3, Dharamvir S Arya 1, Shreesh Ojha 4,*
PMCID: PMC6365674  PMID: 30766488

In the original article, there was an error in Figure 5: The effect of SBT pulp oil on myocardium ultrastructure (scale bar: 500 nm,) as published. There was an error during image processing and some photographs were mistakenly placed in the article. The corrected Figure 5 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 5.

Figure 5

The effect of SBT pulp oil on myocardium ultrastructure (scale bar: 500 nm). (A) Sham; (B) Ischemia-reperfusion control; (C) Seabuckthorn pulp oil 5 ml/kg/day + ischemia-reperfusion; (D) Seabuckthorn pulp oil 10 ml/kg/day + ischemia-reperfusion; (E) Seabuckthorn pulp oil 20 ml/kg/day + ischemia-reperfusion; (F) Seabuckthorn pulp oil 20 ml/kg/day per se; (n = 3; M: mitochondria; N: nucleus; F: myofibrils; Arrow (→ ) indicates myofibrillar damage).

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES